.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Healthtrust
AstraZeneca
Chinese Patent Office
Covington
Colorcon
Merck
Harvard Business School
Cerilliant
US Department of Justice

Generated: July 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075843

« Back to Dashboard
NDA 075843 describes OXAPROZIN, which is a drug marketed by Amneal Pharms Co, Sandoz, Actavis Elizabeth, Sun Pharm Inds Inc, Ivax Sub Teva Pharms, Mylan Pharms Inc, Watson Labs, Teva, Mylan, Dr Reddys Labs Ltd, and Apotex Inc, and is included in thirteen NDAs. It is available from twenty-one suppliers. Additional details are available on the OXAPROZIN profile page.

The generic ingredient in OXAPROZIN is oxaprozin. There are thirteen drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the oxaprozin profile page.

Summary for NDA: 075843

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 075843

Suppliers and Packaging for NDA: 075843

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OXAPROZIN
oxaprozin
TABLET;ORAL 075843 ANDA Apace Packaging 15338-200 15338-200-30 12 BOTTLE in 1 CARTON (15338-200-30) > 30 TABLET, SOLUBLE in 1 BOTTLE
OXAPROZIN
oxaprozin
TABLET;ORAL 075843 ANDA Apace Packaging 15338-211 15338-211-30 12 BOTTLE in 1 CARTON (15338-211-30) > 30 TABLET, SOLUBLE in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength600MG
Approval Date:Oct 3, 2001TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
US Army
Cantor Fitzgerald
Covington
QuintilesIMS
Mallinckrodt
Federal Trade Commission
Julphar
Novartis
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot